MARLEE PRATT: Open Payments
NPI 1225461585 · PORTAGE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,454 in 125 payments from 16 companies in 2025. Trend: 2023 $1,020 · 2024 $1,552 · 2025 $2,454
Food & beverage: $2,266Education: $189
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $351 |
| Janssen Biotech, Inc. | 11 | $315 |
| UCB, Inc. | 18 | $306 |
| Novartis Pharmaceuticals Corporation | 15 | $300 |
| Galderma Laboratories, L.P. | 8 | $246 |
| Lilly USA, LLC | 10 | $205 |
| PFIZER INC. | 5 | $194 |
| GENZYME CORPORATION | 4 | $127 |
| Organon LLC | 7 | $89 |
| E.R. Squibb & Sons, L.L.C. | 3 | $74 |
Products named: TREMFYA, Bimzelx, SKYRIZI, NEMLUVIO, COSENTYX, DUPIXENT, EBGLYSS, LITFULO.
Industry payments across IN — which companies pay providers there.
